Chairs: T. Cortes, T.P. Hughes, D.S. Krause
Speakers at this meeting will present the newest and often unpublished data that relate to the;
1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI
2) Aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells and approaches to cure.
Registration for the meeting is now open. To register go to the ESH website.
Deadline for abstract submission is May 8, 2018. To submit your abstract click here.
From 12-15 October 2017 more than 439 clinicians and scientists from 43 different countries attended the annual John Goldman Conference on CML in Estoril.
“The fact that this meeting takes place for the 19th time this year tells a lot about the passion of the CML scientific community to constantly improving the management of patients with CML and to better understanding the biology of CML”, said Jorge Cortes during the opening ceremony.
As in previous years the scientific sessions focused on various aspects related to the biology and management of CML including; signal transduction pathways involved in CML, possible mechanisms of genomic instability, leukemia stem cells and it's relationship to disease kinetics, challenges of monitoring individual patients with hematologic, cytogenetic and molecular methods, role of allogeneic stem cell transplantation in the management of CML, possible role of different immunotherapeutic approaches in CML, treatment-free survival as an endpoint in CML management and patient reported outcomes and their role in the management of CML patients.
You can view a summary of the scientific program from the perspective of the meeting chairman,Professor Jorge Cortes here.
Early in the morning at 7am, before the Sunday sessions and just a few hours before the Lisbon marathon passed by, participants of the 19th John Goldman Conference on CML – all dressed up in green ‘John Goldman Fun Run’ T-Shirts – started to run along the beautiful Estoril promenade. Despite the early hour everyone had a big smile in their faces enjoying the sea view and the sunrise.
Again this year, all this was for a good cause: by purchasing a bright green ‘iCMLf John Goldman Fund’ running T-Shirt participants supported the training of young physicians from the emerging regions.
From 15-18 September 2016 more than 370 clinicians and scientists from 33 different countries gathered at the Annual John Goldman Conference on CML in Houston to present the newest and often unpublished data related to the biology and clinical management of CML. ‘John Goldman started this conference as a very small meeting a few years ago that has now evolved into one of the most important meetings for scientists and clinicians interested in CML who take each year a lot of new ideas and inspiration from this meeting', said Jorge Cortes during the opening session. Professor Jorge chaired the meeting together with Professor Tessa Holyoake and Professor Tim Hughes.
It has now become a real tradition at the annual John Goldman Conference on CML. Early Sunday morning at 7 am participants pack their running shoes for the 5k ‘John Goldman Fun Run’ to support the work of the International CML Foundation.
This year 35 meeting participants of the 18th John Goldman Conference on CML in Houston had an early start to the day before the Sunday morning sessions, running a 5km loop round through Houston’s beautiful Memorial Park. Even this early in the morning it was already pretty hot and humid. Whether for recreation, or sporting excellence, it was great fun running together with colleagues and friends all while supporting the work of the Foundation.
From October 1-4, 2015 584 clinicians and researchers from 59 countries gathered for the 17th John Goldman Conference to discuss latest findings in the biology and management of CML.
This conference co-sponsored by the iCMLf and the European School of Haematology is also a great opportunity for the CML community to network and exchange experiences and perspectives: “This premier CML meeting usually offers an exciting CML focused scientific program of high-value, but the most important part of this conference are the discussions with other CML experts united in their effort to develop better treatment and care for patients with CML”, said Jorge Cortes during his opening remarks of the congress. Professor Cortes chaired the meeting together with Professor Tessa Holyoake and Professor Tim Hughes.